SELLAS Life Sciences Group, Inc. (SLS) Pre-Tax Margin
- 2013-12-31: Pre-Tax Margin -3191.80%.
- 2013-09-30: Pre-Tax Margin -694.70%.
Complete source-backed pre-tax margin history.
- Available history
- 2013-09-30 to 2022-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2013-12-31 | -3191.80% |
| 2013-09-30 | -694.70% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2022-12-31 | -4130.10% |
| 2021-12-31 | -275.47% |
| 2020-12-31 | -882.84% |
| 2014-12-31 | -303.51% |
| 2013-12-31 | -2825.69% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |